Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.78 - $14.19 $116,700 - $212,850
-15,000 Reduced 30.0%
35,000 $280,000
Q1 2024

May 15, 2024

SELL
$7.59 - $17.47 $13.5 Million - $31.1 Million
-1,779,500 Reduced 97.27%
50,000 $741,000
Q4 2023

Feb 14, 2024

BUY
$3.3 - $8.89 $3.15 Million - $8.49 Million
955,200 Added 109.25%
1,829,500 $14.9 Million
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $3.75 Million - $7.42 Million
844,300 Added 2814.33%
874,300 $3.98 Million
Q1 2023

May 15, 2023

BUY
$5.53 - $8.22 $165,900 - $246,600
30,000 New
30,000 $183,000
Q3 2022

Nov 14, 2022

SELL
$9.53 - $13.11 $2.69 Million - $3.7 Million
-282,100 Reduced 75.81%
90,000 $862,000
Q2 2022

Aug 15, 2022

BUY
$6.38 - $18.33 $2.05 Million - $5.9 Million
322,100 Added 644.2%
372,100 $4.11 Million
Q1 2022

May 13, 2022

SELL
$12.38 - $19.1 $11.5 Million - $17.7 Million
-928,200 Reduced 94.89%
50,000 $833,000
Q4 2021

Feb 11, 2022

BUY
$16.55 - $27.63 $15.7 Million - $26.2 Million
948,200 Added 3160.67%
978,200 $18.7 Million
Q3 2021

Nov 12, 2021

SELL
$20.35 - $26.63 $4.05 Million - $5.3 Million
-199,200 Reduced 86.91%
30,000 $740,000
Q1 2021

May 17, 2021

SELL
$28.67 - $52.59 $567,666 - $1.04 Million
-19,800 Reduced 7.95%
229,200 $7.26 Million
Q4 2020

Feb 16, 2021

BUY
$28.04 - $50.26 $5.58 Million - $10 Million
199,000 Added 398.0%
249,000 $11.6 Million
Q3 2020

Nov 16, 2020

SELL
$27.75 - $36.3 $6.4 Million - $8.37 Million
-230,600 Reduced 82.18%
50,000 $1.65 Million
Q2 2020

Aug 14, 2020

BUY
$27.21 - $41.0 $3.38 Million - $5.1 Million
124,300 Added 79.53%
280,600 $7.7 Million
Q4 2019

Feb 13, 2020

SELL
$17.95 - $29.41 $3 Million - $4.91 Million
-166,900 Reduced 51.64%
156,300 $4.33 Million
Q3 2019

Nov 14, 2019

BUY
$17.99 - $26.0 $5.27 Million - $7.62 Million
293,200 Added 977.33%
323,200 $5.88 Million
Q2 2019

Aug 13, 2019

BUY
$9.78 - $24.52 $293,400 - $735,600
30,000 New
30,000 $735,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.